Tag: Johnson & Johnson

US Agencies Investigate Johnson & Johnson Over Carcinogenic Asbestos In Baby Powder

J&J knew about the asbestos contamination on its baby powder line but failed to notify the public and regulators. The company is facing another bout of inquiry from the U.S. Justice Department and Securities and Exchange Commission.

Public Health February 25, 2019

J&J First Big Pharma Company To Add Prices To Television Product Ads

Johnson & Johnson became the first company to add pricing information on pharmaceutical products being advertised on television. The anticoagulant Xarelto will soon have a list price and out-of-pocket cost in commercials.

Public Health February 9, 2019

Jury Orders J&J To Pay $26 Million Of Damages In Another Talcum Powder Cancer Case

Johnson & Johnson is set to pay almost $26 million after a jury ruled in a talcum powder case. The complainant is diagnosed with mesothelioma, a deadly form of cancer that affects the lungs, heart, and stomach.

Public Health May 26, 2018

Couple Awarded $37 Million In Johnson & Johnson Baby Powder Cancer Lawsuit

Stephen Lanzo claimed he contracted cancer after using Johnson & Johnson's products for more than 30 years. He and his wife were awarded $37 million in compensatory damages on Thursday.

Public Health April 7, 2018

Judge Tosses $417 Million Talcum Powder Case Verdict Against Johnson & Johnson

A judge in Los Angeles has thrown out a $417 million 'talcum powder' case verdict against Johnson & Johnson. Previously, Johnson & Johnson was ordered to pay the sum to a woman who claimed she got ovarian cancer from the company's baby powder product.

Public Health October 21, 2017

Johnson & Johnson Ordered To Pay $417 Million In Lawsuit Tying Baby Powder To Ovarian Cancer

Eva Echeverria claimed she would have stopped using Johnson & Johnson's talcum powder had a warning been placed on it. What do scientific studies say about the link between baby powder and ovarian cancer?

Public Health August 22, 2017

Australian Class Action Case Filed Against Johnson & Johnson Over Vaginal Mesh Implants

More than 700 women in Australia have filed a class action lawsuit against Johnson & Johnson over its vaginal mesh implants. The plaintiffs argued that the devices caused them to suffer excruciating and irreparable pain.

Public Health July 5, 2017

J&J Drug May Reduce Heart Events In Diabetes Patients But Doubles Risk For Toe, Lower Foot Amputations

Invokana can significantly reduce heart events in type 2 diabetes patients but doubles risk for toe and lower foot amputations. How does Johnson & Johnson's Invokana fare compared with rival drug Jardiance?

Medicine June 13, 2017

Woman Who Blames Baby Powder For Her Ovarian Cancer Wins Lawsuit: Should You Stop Using Talcum Powder?

Johnson & Johnson has lost another lawsuit connected to its cosmetic powders but the company continues to defend its products. Is it time to throw out talc-based products?

Public Health May 6, 2017

Johnson & Johnson Ordered To Pay More Than $110 Million In Baby Powder, Shower To Shower Powder Cancer Case

Johnson & Johnson was ordered to pay more than $110 million to a woman who claimed to have developed ovarian cancer after using the company's talc-based products for many years. What do studies say about the talcum powder and ovarian cancer link?

Public Health May 5, 2017

Johnson & Johnson Ordered To Pay More Than $1 Billion To Patients Injured By Pinnacle Hip Implants

Johnson & Johnson and DePuy Orthopedics were ordered to pay $1.04 billion in compensatory and punitive damages to patients who were injured by the metal-on-metal Pinnacle hip implants. The amount is the third largest jury award of 2016.

Feature | Health December 1, 2016

Jury Awards $70 Million To Ovarian Cancer Patient In Johnson & Johnson Baby Powder Lawsuit

A jury has awarded a California woman more than $70 million in a lawsuit that claims the use of Johnson & Johnson's baby powder caused her ovarian cancer. About 2,000 women have already filed similar suits that question the safety of the talcum powder.

Public Health October 28, 2016

More Cancer-Related Talcum Powder Lawsuits Filed Against Johnson & Johnson

Johnson & Johnson is facing a new lawsuit from a woman in California who claims the company's talcum powder has given her ovarian cancer. The company argues there is no scientific evidence to support the link.

Public Health September 27, 2016

Johnson & Johnson Subsidiary Acclarent Settles Medical Device-Related Allegations For $18 Million

J&J's subsidiary Acclarent pays $18 million in U.S. court settlement to resolve accusations related to an unapproved medical device. The marketing and distribution of said device resulted in false claims submitted to Medicare and other federal health programs.

Medicine July 25, 2016

Johnson & Johnson Faces More than 1,000 Lawsuits Over Talcum Powder

Johnson & Johnson is facing about 1,200 lawsuits accusing it of ignoring studies that link its baby powder to ovarian cancer. The cases highlight the talc and ovarian cancer link - and how the company allegedly failed to warn consumers.

Healthy Living/Wellness May 4, 2016

Jury Orders Johnson & Johnson To Pay $55 Million Over Talc-Based Powder Linked To Ovarian Cancer

Johnson & Johnson was ordered to pay damages to a South Dakota woman who developed ovarian cancer after decades of using the company's talc powder products. The company faces 1,200 other similar lawsuits.

Public Health May 2, 2016

FDA Gives Approval To Knockoff Version Of Johnson & Johnson Remicade Drug

The U.S. Food and Drug Administration has approved Johnson & Johnson's Remicade biosimilar, Inflectra. Now, doctors may prescribe this infliximab drug to patients.

Life April 6, 2016

EU Recommends Conditional Approval For Johnson & Johnson's Blood Cancer Drug Darzalex

European regulators on April 1 issued a conditional approval recommendation for the use of Johnson & Johnson's Darzalex in patients with blood cancer. The committee is awaiting more data from two ongoing studies.

Life April 3, 2016

Johnson & Johnson Lawsuit: Can Talcum Powder Cause Cancer?

Johnson & Johnson is in hot water after its baby products were linked to cancer.

Life February 26, 2016

Johnson & Johnson Loses $72 Million In Suit Linking Talcum Powder To Cancer

A St. Louis jury ordered Johnson & Johnson to pay $72 million in damages to the family of a dead woman who used the company's talcum powder for several decades. What’s the link between talc and ovarian cancer?

Life February 25, 2016

FDA Advisory Panel Recommends Approval Of Remicade Knockoff

An FDA advisory panel approved a knockoff arthritis drug called Remsima from Pfizer Inc. and Celltrion Inc. The drug is the biosimilar version of Amgen's Remicade, which has brought billions of profits for the company.

Life February 10, 2016

Eli Lilly's Jardiance Diabetes Treatment Steals Market Share From Rival Drugs

Eli Lilly's new diabetes treatment Jardiance stole market share from its rivals. The increased market share of 25 percent of new U.S. patients was attributed to clinical trial data showing fewer deaths among type 2 diabetics by 32 percent.

Life January 7, 2016

Johnson & Johnson Advanced Multiple Myeloma Drug Darzalex Wins Accelerated FDA Approval

Newly approved multiple myeloma drug Darzalex offers hope for patients whose prior treatments failed to deliver results. The drug binds to proteins in tumor cells causing them to die and leaving healthy cells unharmed.

Life November 17, 2015

Revolutionary HIV Treatment Could Be Underway As Clinical Trial Shows Promising Result For Combination Drug

A combination drug from Johnson & Johnson and ViiV Healthcare showed promising results in suppressing HIV in a clinical trial. Initial results showed the long-lasting injectable drugs can suppress the virus when taken regularly.

Life November 4, 2015

Johnson & Johnson Starts Clinical Trial Of Ebola Vaccine In Sierra Leone

The EBOVAC-Salone study will evaluate the efficacy and safety of Johnson & Johnson's experimental Ebola vaccine. The clinical trial will take place in Sierra Leone's Kambia district.

Life October 9, 2015

Johnson & Johnson Calls On Ethicists To Weigh In On Drug Trials

Who gets what and when? Johnson & Johnson is getting some help from ethicists regarding decisions about requests for compassionate use of investigational medicines.

Life May 8, 2015

IBM Establishes Watson Health Cloud With Apple, J&J, And Medtronic

IBM partners with Apple, Johnson & Johnson and Medtronics to boost Watson Health Cloud capabilities, taking advantage of personalized information to improve how health care is delivered to patients.

Life April 14, 2015

Google To Build Surgical Robots With Johnson & Johnson

Google has partnered with Johnson & Johnson to develop and build surgical robots in order to offer surgeons more options and precision in surgery. The terms of the agreement have not yet been disclosed.

FUTURE TECH March 28, 2015

Tylenol Maker Admits To Selling Drugs Contaminated With Metals

Johnson & Johnson subsidiary will pay $25 million to settle a suit over children's medications contaminated in faulty manufacturing. Infants' Tylenol and Children's Motrin were both subjects of recall in 2010.

Life March 11, 2015

Boston Scientific, Johnson & Johnson Bury The Hatchet With $600 Million Settlement

Boston Scientific has been in a lot of hot water since it acquired Guidant in 2006. With this settlement, it is finally making peace with Johnson & Johnson and moving on.

Life February 20, 2015

J&J Gets $115M to Push Out Ebola Vaccine Faster

Johnson & Johnson has received $115 to speed development of a vaccine for Ebola. Where do we currently stand in our fight against the disease?

Life January 16, 2015

Johnson & Johnson halts sale of power morcellators for fibroid surgery

Following warning from the FDA of the risks associated with laparoscopic power morcellation in removing fibroids, Johnson & Johnson pulled out its power morcellators worldwide albeit temporarily.

Life April 30, 2014

FDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd time

The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time.

Life February 17, 2014

Real Time Analytics